USD 18.09
(-23.41%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -595.8 Million | -561.31 Million | -688.13 Million | -232 Million | -245.79 Million | -209.26 Million |
Net Income | -1.46 Billion | -5.39 Billion | -1.24 Billion | -312.15 Million | -244.85 Million | -275.71 Million |
Depreciation & Amortization | 158.69 Million | 154.76 Million | 58.44 Million | 7.56 Million | 10.3 Million | 14.08 Million |
Deferred income taxes | -38.15 Million | -39.06 Million | -17.47 Million | - | - | - |
Stock-based compensation | 20.32 Million | 34.72 Million | 681.9 Million | 45.99 Million | 28.39 Million | - |
Change in working capital | 7.72 Million | -14.46 Million | 21.58 Million | 17.21 Million | -39.28 Million | 39.67 Million |
Other non-cash items | 1.05 Billion | 5.06 Billion | 625.24 Million | 9.38 Million | 55.19 Million | 41.2 Million |
Investing Cash Flow | -12.88 Million | -22.85 Million | 344.81 Million | -12.79 Million | 133.03 Million | -93.39 Million |
Investments in PPE | -12.88 Million | -22.85 Million | -69.92 Million | -11.9 Million | -3.33 Million | -15.98 Million |
Acquisitions | - | - | - | - | 82 Thousand | 476 Thousand |
Investment purchases | - | - | -159.41 Million | - | -551.51 Million | -681.13 Million |
Sales/Maturities of investments | - | - | 574.14 Million | - | 687.8 Million | 603.25 Million |
Other Investing Activities | - | - | 414.73 Million | -885 Thousand | 136.36 Million | - |
Financing Cash Flow | 463.76 Million | 604.81 Million | 394.74 Million | 275.1 Million | 160.32 Million | 300.61 Million |
Debt repayment | - | - | - | -812 Thousand | -1.55 Million | -1.51 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -234 Thousand | -4.18 Million | -170 Thousand | - | -261 Thousand | -282 Thousand |
Common Stock Issuance | - | - | 5.98 Million | - | 162.14 Million | 302.41 Million |
Other Financing Activities | 463.76 Million | 604.81 Million | 388.93 Million | 275.92 Million | -932 Thousand | - |
Accounts receivables | -1.38 Million | -8.67 Million | -6.88 Million | - | - | - |
Accounts payables | 2.88 Million | 2.34 Million | 1.29 Million | - | -6.54 Million | -338 Thousand |
Inventory | -1.94 Million | -14.08 Million | -5.67 Million | - | - | - |
Other working capital | 8.15 Million | 5.95 Million | 32.84 Million | 17.21 Million | -32.73 Million | 40.01 Million |
Cash at beginning of period | 241.59 Million | 225.99 Million | 143.18 Million | 144.41 Million | 95.09 Million | 97.12 Million |
Cash at end of period | 97.28 Million | 241.59 Million | 802.03 Million | 174.76 Million | 143.18 Million | 95.09 Million |
Capital Expenditure | -12.88 Million | -22.85 Million | -69.92 Million | -11.9 Million | -3.33 Million | -15.98 Million |
Effect of forex changes on cash | 305 Thousand | -511 Thousand | -199 Thousand | 36 Thousand | 124 Thousand | - |
Net cash flow / Change in cash | -144.3 Million | 15.6 Million | 658.84 Million | 30.35 Million | 48.09 Million | -2.03 Million |
Free Cash Flow | -608.68 Million | -584.17 Million | -758.05 Million | -243.9 Million | -249.12 Million | -225.24 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.58 Billion | -218.91 Million | -1.46 Billion | -193.04 Million | -193.66 Million | -5.39 Billion |
Depreciation & Amortization | 39.38 Million | 39.99 Million | 158.69 Million | 39.12 Million | 39.84 Million | 154.76 Million |
Deferred income taxes | -53.14 Million | -4.8 Million | -38.15 Million | -9.05 Million | -7.01 Million | -39.06 Million |
Stock-based compensation | 25.94 Million | -13.8 Million | 20.32 Million | 25.54 Million | 5.44 Million | 34.72 Million |
Change in working capital | -9 Million | -9.81 Million | 7.72 Million | 7.03 Million | -14.83 Million | -14.46 Million |
Other non-cash items | 1.51 Billion | 71.91 Million | 1.05 Billion | 93.71 Million | 90.3 Million | 5.06 Billion |
Investing Cash Flow | -1.38 Million | -2.54 Million | -12.88 Million | -2.85 Million | -3.06 Million | -22.85 Million |
Investments in PPE | -1.38 Million | -2.54 Million | -12.88 Million | -2.85 Million | -3.06 Million | -22.85 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 932.3 Million | 312 Million | 463.76 Million | 194.9 Million | 108.87 Million | 604.81 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -234 Thousand | - | - | -4.18 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 932.3 Million | 312 Million | 463.76 Million | 194.9 Million | 108.87 Million | 604.81 Million |
Accounts receivables | 1.62 Million | 1.91 Million | -1.38 Million | -581 Thousand | 5.01 Million | -8.67 Million |
Accounts payables | 4.39 Million | -7.7 Million | 2.88 Million | 2.54 Million | -7.92 Million | 2.34 Million |
Inventory | -3.92 Million | 117 Thousand | -1.94 Million | -386 Thousand | -2.52 Million | -14.08 Million |
Other working capital | -11.09 Million | -4.13 Million | 8.15 Million | 5.45 Million | -9.4 Million | 5.95 Million |
Cash at beginning of period | 199.72 Million | 101.51 Million | 241.59 Million | 181.58 Million | 166.81 Million | 225.99 Million |
Cash at end of period | 958.84 Million | 199.72 Million | 97.28 Million | 234.84 Million | 181.58 Million | 241.59 Million |
Capital Expenditure | -1.38 Million | -2.54 Million | -12.88 Million | -2.85 Million | -3.06 Million | -22.85 Million |
Effect of forex changes on cash | 7000.00 | -37 Thousand | 305 Thousand | 129 Thousand | 128 Thousand | -511 Thousand |
Net cash flow / Change in cash | 759.12 Million | 98.21 Million | -144.3 Million | 53.26 Million | 14.76 Million | 15.6 Million |
Free Cash Flow | -173.18 Million | -209.83 Million | -608.68 Million | -141.76 Million | -173.54 Million | -584.17 Million |
KEFI
002557
CF
MYD
NRC
GSSRF